Canadian Consortium on Neurodegeneration in Aging (CCNA)

Related links

Read the transcript

As a dynamic research enterprise, the Canadian Consortium on Neurodegeneration in Aging (CCNA) will be the premier research hub for all aspects of research involving neurodegenerative diseases that affect cognition in aging – including Alzheimer's disease. The CCNA is supported by CIHR and many partners and is the Canadian component of the CIHR Dementia Research Strategy.

What is the CCNA?

The vision of the CCNA is to bring together the best of Canadian research in the field of neurodegenerative diseases affecting cognition in a collaborative and synergistic space. Researchers are working on bold and transformative research ideas to make a difference in the quality of life and the quality of services for those living with the effects of neurodegenerative diseases affecting cognition and their caregivers.

The CCNA includes research in Alzheimer's disease and research collaborations with those working on other neurodegenerative diseases. While neurodegenerative diseases of aging that have an impact on cognition may manifest differently, they share common causation, risk factors, health care, ethical and quality of life issues, and require similar research approaches and resources.

The CCNA is promoting high impact, inter-institutional and interdisciplinary collaboration through a pan-Canadian approach, and will position Canadian researchers to lead and participate in a new wave of national and international initiatives with congruent goals.

Goal and objectives

The goal of the CCNA is to support a collaborative, integrated, strategically oriented, bold, transformative and highly impactful Canadian Consortium on Alzheimer's and other neurodegenerative diseases in aging having an impact on cognition, in order to reach these objectives:

  • Strengthen and synergize Canadian innovative and collaborative research;
  • Become the Canadian hub for leading and participating in international research collaborations;
  • Reinforce the international positioning, competitiveness and impact of Canadian research at the global level;
  • Ultimately impact the quality of life and the quality of services for those having to live with the effects of neurodegenerative diseases affecting cognition and their caregivers.

What areas of research will the CCNA support?

Research within the CCNA is organized around three research themes that are in line with the overall goals of the Strategy which is to prevent and mitigate the toll of dementia and related neurodegenerative diseases of aging that have an impact on cognition for individuals and society.

The three themes are:

  • Primary Prevention – aimed at preventing the disease from developing;
  • Secondary Prevention – focused on delaying the clinical manifestations of the already developing disease; and
  • Quality of Life – designed for helping individuals, caregivers and the health system in the context of a clinically developed disease.

The CCNA is led by Scientific Director Dr. Howard Chertkow, supported by Principal Investigators for each of the research themes.

Contact information

Sharon Nadeau
Phone: 613-946-1136
DRS-SRD@cihr-irsc.gc.ca

Date modified: